- New York Sues Sackler Family Members and Drug Distributors (nytimes.com)
New York State...laid out one of the most detailed and sweeping legal cases yet against the family that owns Purdue Pharma…The lawsuit, filed by the state attorney general Letitia James, is one of the very few in a wave of opioid litigation across the country that name the Sacklers. It targets eight family members: Richard, Jonathan, Mortimer, Kathe, David, Beverly and Theresa Sackler, as well as Ilene Sackler Lefcourt...The lawsuit, filed in New York State Supreme Court...seeks to recover the state’s costs for unnecessary prescriptions and related health care expenses, along with financial penalties...The suit also seeks to claw back funds that it alleges were transferred from Purdue Pharma to private or offshore accounts held by members of the Sackler family in an effort to shield the assets from litigation; to order the Sacklers to return any transferred assets; and to restrain them from disposing of any property...READ MORE
- Purdue eyes bankruptcy filing to cope with mounting opioid accusations: Reuters (fiercepharma.com)Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy -sources (reuters.com)
Purdue Pharma may file for bankruptcy to get out from under thousands of lawsuits blaming the opioid maker and its aggressive marketing for the addiction crisis...The drugmaker is battling a weight of litigation, including state claims that target its executives and founding family, claiming it misled doctors and patients and marketed its painkillers too aggressively, helping to create a nationwide opioid crisis. Now, the company is exploring bankruptcy as a way to cope with the amassing litigation...A bankruptcy filing would halt proceedings in the lawsuits and allow Purdue to negotiate with plaintiffs under the watch of a bankruptcy judge...READ MORE
- Insys executive gave doctor lap dance while promoting drug, witness says (reuters.com)
An ex-stripper who became a regional sales director at Insys Therapeutics Inc gave a doctor a lap dance at a Chicago club as the drugmaker pushed the doctor to prescribe its addictive fentanyl spray, a former Insys employee testified...The testimony in federal court...came in the first criminal trial of painkiller manufacturer executives over conduct that authorities say contributed to a U.S. opioid abuse epidemic... Former Insys sales representative Holly Brown told jurors the incident with her boss, Sunrise Lee, took place after Insys began rewarding the doctor for prescribing its opioid product by paying him to speak at educational events about the drug...That Illinois doctor, Paul Madison, is one of several whom prosecutors say Lee and four other former Insys executives and managers including wealthy founder and ex-chairman John Kapoor conspired to bribe to boost sales of the spray, Subsys
- Judge blocks Trump administration cuts to 340B hospital drug-discount program (statnews.com)
A federal judge has blocked a Trump administration policy that reduces payments to hospitals under a drug discount program, ruling...that the government overstepped its authority in an attempt to address the high cost of prescription medications...The decision is a win for the 2,000-plus hospitals participating in the program, known as 340B, most of which serve large numbers of low-income patients...In 2017, the Department of Health and Human Services reduced its reimbursements for some drugs by about 28 percentage points...
- Purdue Pharma agrees to $270 million settlement in Oklahoma opioid case (reuters.com)
OxyContin maker Purdue Pharma LP...reached a $270 million settlement to resolve a lawsuit brought by the state of Oklahoma accusing the drugmaker of fueling an opioid abuse epidemic...The settlement unveiled by Oklahoma Attorney General Mike Hunter...was the first to result from a wave of lawsuits accusing Purdue of deceptively marketing painkillers, helping create a deadly crisis sweeping the United States...Hunter alleged Purdue, Johnson & Johnson and Teva Pharmaceutical Industries Ltd engaged in deceptive marketing that downplayed the addiction risk from opioids while overstating their benefits, contributing to the epidemic...READ MORE
- AG will recuse on selecting outside legal help for opioid lawsuit (thenevadaindependent.com)
Attorney General Aaron Ford is seeking an outside firm to represent the state in a major lawsuit against some of the nation’s largest opioid manufacturers...members of the legislative Interim Finance Committee granted the attorney general’s office permission...to open up bidding for an outside law firm to represent the state in litigation against opioid manufacturers. Ford...who...worked for a private law firm that is representing numerous Nevada municipalities in class action lawsuits, also said...that he will recuse himself from selection of outside counsel...State Consumer Advocate Ernest Figueroa, who presented the request to lawmakers, gave few details on the proposed litigation beyond stating that approval from the interim body was a required step under state law. He cited a declaration of findings signed by Ford and Gov. Steve Sisolak on Jan. 23 saying the state likely required additional legal resources to pursue litigation against companies that engaged in “unlawful and deceptive practices marketing of prescription opioids.”
- Walgreens pays $269.2 million to settle U.S. civil fraud lawsuits (reuters.com)
Walgreens Boots Alliance Inc will pay $269.2 million to settle two whistleblower lawsuits accusing it of civil fraud for overbilling federal healthcare programs over a decade, the U.S. Department of Justice said...The pharmacy chain will pay $209.2 million to resolve claims it improperly billed Medicare, Medicaid and other federal programs from 2006 to 2017 for hundreds of thousands of insulin pens it dispensed to patients it knew did not need them...Walgreens will also pay $60 million to resolve claims it overcharged Medicaid from 2008 to 2017 by failing to disclose and charge the discount drug prices it offered the public through its Prescription Savings Club program...Two pharmacists filed the original complaint concerning the insulin pens in July 2015. A copy of that complaint could not immediately be obtained on Tuesday...Marc Baker, who worked for Walgreens for a decade as a pharmacy manager in Florida, filed the original complaint concerning the drug price discounts in January 2012.
- Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial (reuters.com)
Oklahoma’s top court...declined to delay a landmark trial set for May in a multibillion-dollar lawsuit accusing OxyContin maker Purdue Pharma LP and two other drugmakers of helping fuel an opioid abuse and overdose epidemic in the state...The Oklahoma Supreme Court’s decision was a win for the state’s attorney general, whose case is set to be the first to face trial of roughly 2,000 lawsuits nationally seeking to hold opioid manufacturers responsible for contributing to the epidemic...Oklahoma Attorney General Mike Hunter’s 2017 lawsuit accuses Purdue, Johnson & Johnson & Teva Pharmaceutical Industries Ltd of engaging in deceptive marketing that downplayed the risks of addiction associated with opioid pain drugs while overstating their benefits...READ MORE
- Opioid Lawsuits Are Headed to Trial. Here’s Why the Stakes Are Getting Uglier. (nytimes.com)
The judge presiding over all the federal cases had hoped to settle them by now. But the behemoth litigation is only becoming more bloated, contentious and difficult to resolve...Judge Dan Aaron Polster will preside over three consolidated lawsuits as a bellwether, or test case, in one of the most complicated legal battles in U.S. history...
Uncontested:The devastation from prescription opioids has been deadly and inordinately expensive
Contested: Who should foot the bill?
...litigation has ballooned to 1,548 federal court cases, brought on behalf of cities and counties, 77 tribes, hospitals, union benefit funds, infants with neonatal abstinence syndrome and others — in total, millions of people. With a potential payday amounting to tens of billions of dollars...
- Stunning evidence from D.E.A. records
- Going to trial is a win for plaintiffs
- The companies demand personal medical records
- Meanwhile, the plaintiffs pursue their own paper chase
- Drugstores could be held responsible for black-market fentanyl
- Why drug companies could have an upper hand
- But don't count out the plaintiffs
- But wait! There’s more! - Johns Hopkins, Bristol-Myers must face $1 billion syphilis infections suit (reuters.com)
A federal judge in Maryland said The Johns Hopkins University, Bristol-Myers Squibb Co and the Rockefeller Foundation must face a $1 billion lawsuit over their roles in a 1940s U.S. government experiment that infected hundreds of Guatemalans with syphilis...In a decision on Thursday, U.S. District Judge Theodore Chuang rejected the defendants’ argument that a recent Supreme Court decision shielding foreign corporations from lawsuits in U.S. courts over human rights abuses abroad also applied to domestic corporations absent Congressional authorization...Chuang’s decision is a victory for 444 victims and relatives of victims suing over the experiment, which was aimed at testing the then-new drug penicillin and stopping the spread of sexually-transmitted diseases...